Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Selectis Health (GBCS) Return on Sales (2017 - 2025)

Historic Return on Sales for Selectis Health (GBCS) over the last 14 years, with Q3 2025 value amounting to 0.05%.

  • Selectis Health's Return on Sales rose 1200.0% to 0.05% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.06%, marking a year-over-year increase of 1500.0%. This contributed to the annual value of 0.12% for FY2024, which is 1800.0% up from last year.
  • As of Q3 2025, Selectis Health's Return on Sales stood at 0.05%, which was up 1200.0% from 0.06% recorded in Q2 2025.
  • Selectis Health's 5-year Return on Sales high stood at 0.09% for Q2 2022, and its period low was 0.4% during Q4 2023.
  • For the 5-year period, Selectis Health's Return on Sales averaged around 0.13%, with its median value being 0.14% (2024).
  • Its Return on Sales has fluctuated over the past 5 years, first tumbled by -3300bps in 2023, then skyrocketed by 3600bps in 2024.
  • Quarter analysis of 5 years shows Selectis Health's Return on Sales stood at 0.19% in 2021, then fell by -6bps to 0.21% in 2022, then tumbled by -94bps to 0.4% in 2023, then surged by 89bps to 0.04% in 2024, then decreased by -6bps to 0.05% in 2025.
  • Its Return on Sales stands at 0.05% for Q3 2025, versus 0.06% for Q2 2025 and 0.09% for Q1 2025.